14.52
+0.49(+3.49%)
Currency In USD
Address
465 State Route 17
Ramsey, NJ 07446
United States of America
Phone
201 478 5552
Sector
Healthcare
Industry
Biotechnology
Employees
685
First IPO Date
October 17, 2013
| Name | Title | Pay | Year Born |
| Mr. Adam S. Grossman | Co-Founder, President, Chief Executive Officer & Director | 1.86M | 1977 |
| Dr. Jerrold B. Grossman D.P.S., Ph.D. | Co-Founder & Vice Chairman of the Board | 90,000 | 1948 |
| Mr. Brad Tade | Chief Financial Officer & Treasurer | 680,951 | 1974 |
| Ms. Kaitlin Kestenberg | Chief Operating Officer & Senior Vice President of Compliance | 815,808 | 1987 |
| Mr. Michael Goldstein | General Counsel | 0 | N/A |
| Mr. Drew Pantello | Vice President of Marketing & Corporate Development | 0 | N/A |
| Ms. Cindy Petersen | Vice President of Human Resources | 0 | N/A |
| Mr. John Hafl | Executive Director of Sales | 0 | N/A |
| Mr. Skyler Bloom | Senior Director of Business Development & Corporate Strategy | 0 | N/A |
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
